Correction to: Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO.

Regnault, Antoine; Morel, Thomas; de la Loge, Christine; Mazerolle, Flora; Kaminski, Henry J; Habib, Ali A

Regnault, Antoine; Morel, Thomas; de la Loge, Christine; Mazerolle, Flora; Kaminski, Henry J; Habib, Ali A.

Afiliação

Regnault A; Modus Outcomes, A Division of THREAD, Lyon, France.
Morel T; UCB Pharma SRL, Allée de la Recherche, 60, 1070, Brussels, Belgium. Thomas.Morel@ucb.com.
de la Loge C; PCOM Analytics, Avallon, France.
Mazerolle F; Modus Outcomes, A Division of THREAD, Lyon, France.
Kaminski HJ; Department of Neurology and Rehabilitation Medicine, George Washington University, Washington, DC, USA.
Habib AA; Department of Neurology, University of California, Irvine, CA, USA.

Neurol Ther ; 12(5): 1591-1592, 2023 Oct.

Article em En | MEDLINE | ID: mdl-37368226

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Neurol Ther Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google